Safety of Diclofenac Sodium Gel in Knee Osteoarthritis

Novartis

Status and phase: Completed; Phase 3

Conditions: Osteoarthritis

Treatments: Drug: Diclofenac Topical Sodium Gel 1%

Study type: Interventional

Funder types: Industry

Identifiers

NCT00171691

VOSG-PN-309

Details and patient eligibility

About

This study will test the efficacy and safety of topical Voltaren in the treatment of knee osteoarthritis.

Sex: All

Ages: 35+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Key Inclusion criteria

• Osteoarthritis of the knee

Key Exclusion criteria

• Other rheumatic disease, such as rheumatoid arthritis
• Active gastrointestinal ulcer during the last year
• Known allergy to analgesic drugs

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)